Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.68p
   
  • Change Today:
      0.000p
  • 52 Week High: 20.50
  • 52 Week Low: 1.65
  • Currency: UK Pounds
  • Shares Issued: 154.32m
  • Volume: 3,007,429
  • Market Cap: £2.58m
  • RiskGrade: 747

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
17.32% above the market average17.32% above the market average17.32% above the market average17.32% above the market average17.32% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
72.74% above the market average72.74% above the market average72.74% above the market average72.74% above the market average72.74% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Book Ratio
13.85% below the market average13.85% below the market average13.85% below the market average13.85% below the market average13.85% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
99.76% below the market average99.76% below the market average99.76% below the market average99.76% below the market average99.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Chg 3m
97.84% below the market average97.84% below the market average97.84% below the market average97.84% below the market average97.84% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
74.07% below the market average74.07% below the market average74.07% below the market average74.07% below the market average74.07% below the market average
82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average
Momentum 20
79.26% below the market average79.26% below the market average79.26% below the market average79.26% below the market average79.26% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
97.78% below the market average97.78% below the market average97.78% below the market average97.78% below the market average97.78% below the market average
93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
76.75% below the market average76.75% below the market average76.75% below the market average76.75% below the market average76.75% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average
93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average
Operating Profit Loss
70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Cash
38.72% below the market average38.72% below the market average38.72% below the market average38.72% below the market average38.72% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 1.68p
Change Today 0.000p
% Change 0.00 %
52 Week High 20.50
52 Week Low 1.65
Volume 3,007,429
Shares Issued 154.32m
Market Cap £2.58m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.14% below the market average8.14% below the market average8.14% below the market average8.14% below the market average8.14% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Price Trend
97.8% below the market average97.8% below the market average97.8% below the market average97.8% below the market average97.8% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average
Income Not Available
Growth
43.1% below the market average43.1% below the market average43.1% below the market average43.1% below the market average43.1% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

Genedrive Dividends

No dividends found

Trades for 22-May-2024

Time Volume / Share Price
16:13 8,500 @ 1.68p
16:11 5,882 @ 1.70p
16:08 59,166 @ 1.68p
16:05 16,379 @ 1.66p
16:04 292 @ 1.65p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page